Screener
Aptevo Therapeutics APVO Q3 2025 earnings
Reported November 6, 2025 · Before market open
EPS-$40.11Miss by $2.52
EPS estimate-$37.59
Next report
Nov 5, 2026 (in 2 months)EPS estimate-$3.72
Versus estimates
Diluted EPS
FAQ
- When did Aptevo Therapeutics report Q3 2025 earnings?
- Aptevo Therapeutics (APVO) reported Q3 2025 earnings on November 6, 2025 before market open.
- What were Aptevo Therapeutics's Q3 2025 revenue and EPS?
- Aptevo Therapeutics reported eps of $-40.11 for Q3 2025.
- Did Aptevo Therapeutics beat estimates in Q3 2025?
- EPS missed the consensus estimate of $-37.59 by $2.52.
- How did Aptevo Therapeutics's Q3 2025 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 99.4% from $-6255.86.
- Where can I find Aptevo Therapeutics's Q3 2025 SEC filings?
- You can read the 8-K earnings release (0001193125-25-269470) and the 10-Q periodic report (0001193125-25-269598) directly on SEC EDGAR. The filing index links above go to sec.gov.
